Molicules

Abiraterone Ethyl Ether

Abiraterone Ethyl Ether is a derivative of Abiraterone, a medication used in the treatment of prostate cancer. Abiraterone acts as an androgen biosynthesis inhibitor, meaning it inhibits the production of androgens (male hormones) in the body, which are known to fuel the growth of prostate cancer cells.

Abiraterone Ethyl Ether is a chemical modification or derivative of Abiraterone. Specifically, it is an ether derivative, where an ethyl ether group has been introduced into the molecular structure of Abiraterone.

banner

This modification might have been done to alter the properties of the compound, such as its solubility, stability, or potency, or to explore its potential as a novel therapeutic agent.

Structural modifications can sometimes enhance the potency or efficacy of a drug, making it more effective at its intended target.

Developing new derivatives of existing drugs can provide opportunities for patent protection, allowing companies to extend their exclusivity on the drug and recoup investment in research and development.

Derivatives of known drugs can sometimes exhibit activity against different targets or pathways, opening up new avenues for therapeutic intervention.

  • CAT NO : AE-00006
  • CAS No : 2484719-14-2
  • Mol.F. : C26H35NO
  • Mol.Wt. : 377.5
  • Inv. Status: In Stock
  • Technical Certificate